The study, presented at the American Society for Bone and Mineral Research 2019 Annual Meeting, described the experience of patients who initiated treatment with abaloparatide.
Researchers investigated the safety and efficacy of twice-weekly 28.2 μg teriparatide compared with once-weekly 56.5 μg teriparatide in Japanese patients with osteoporosis.
Long-term use of calcium supplements is not associated with increased risk for development or progression of abdominal aortic calcification in older women.
Red cell distribution width, a measure of the amount of variability in the size of red blood cells, is routinely assessed in blood counts and may accurately predict risk for hip fracture.
Screening and treatment of osteoporosis is statistically lower in black Americans, which may be related to the differences in fracture outcomes according to race.
Maternal cholecalciferol supplementation may have lasting benefits for offspring musculoskeletal health.
Patients with greater BMD improvement after 1 year of denosumab are more likely to lose BMD after the transition to alendronate therapy in the second year.
There are significant relationships between bone marrow density, visceral adipose tissue, and bone indices in children.